Does Rallies show 13F holders for QTTB?

Yes. Rallies tracks hedge fund and 13F ownership data for QTTB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is QTTB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for QTTB. It does not provide personalized investment advice.

QTTB (Q32 Bio Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of May 21, 2026, QTTB trades at $5.82 with a market cap of $97.50M and a P/E ratio of 2.04. QTTB moved -6.43% today. Year to date, QTTB is +68.25%; over the trailing twelve months it is +220.34%. Its 52-week range spans $1.35 to $53.17. Analyst consensus is buy with an average price target of $14.33. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns QTTB stock?

Hedge funds tracked by Rallies that own QTTB include Orbimed Advisors and Temasek Holdings. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Q32 Bio Inc. Common Stock.

QTTB Key Metrics

Key financial metrics for QTTB
Metric	Value
Price	$5.82
Market Cap	$97.50M
P/E Ratio	2.04
EPS	$2.79
Dividend Yield	0.00%
52-Week High	$53.17
52-Week Low	$1.35
Volume	526
Avg Volume	0
Revenue (TTM)	$53.92M
Net Income	$33.24M
Gross Margin	0.00%

Top Hedge Funds Holding QTTB

Orbimed Advisors holds 2.25M shares of QTTB, changed +0.00% as of Mar 31, 2026.
Temasek Holdings holds 313.94K shares of QTTB, changed +0.00% as of Dec 31, 2024.

Latest QTTB News

Q32 Bio Raises $10.5M, Holds $50.8M Cash and Doses First Open-Label Extension Patient — May 5, 2026
Q32 Bio to Present at Needham Conference April 15; Webcast Available for 90 Days — Apr 8, 2026
Q32 Bio Raises $10.5M, Extends Cash Runway to Q4 2027 — Mar 10, 2026
Q32 Bio sells asset for $12M plus up to $592M, eyes mid-2026 bempikibart data — Mar 1, 2026
Q32 Bio Secures $10.5M Financing with 1.67M Shares and 1.03M Warrants — Feb 17, 2026

Recent QTTB Insider Trades

Kalowski Lee sold 4.00K (~$18.04K) on Feb 25, 2026.
Morrison Jodie Pope sold 9.90K (~$44.67K) on Feb 25, 2026.
Violette Shelia M. sold 2.81K (~$12.71K) on Feb 25, 2026.

QTTB Analyst Consensus

3 analysts cover QTTB: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.33.

Common questions about QTTB

Who owns QTTB stock?: Hedge funds tracked by Rallies that own QTTB include Orbimed Advisors and Temasek Holdings. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Q32 Bio Inc. Common Stock.
Does Rallies show 13F holders for QTTB?: Yes. Rallies tracks hedge fund and 13F ownership data for QTTB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is QTTB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for QTTB. It does not provide personalized investment advice.